CTI BioPharma Settles Investor Testing Info Row For $20M

Law360, New York (September 5, 2017, 5:25 PM EDT) -- CTI BioPharma Corp. and its executives will pay $20 million to a proposed class of investors for allegedly withholding information about patient deaths during clinical trials for a myelofibrosis drug, which...

We take your privacy seriously. As detailed in our Privacy Policy we will use your personal information to administer your account and provide the products and services that you have requested from us.

We take your privacy seriously. As detailed in our Privacy Policy we will use your personal information to administer your account and provide the products and services that you have requested from us.